Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 2:15 p.m. PT.
Related news for (RLAY)
- MoBot’s Stock Market Highlights – 09/26/25 07:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/26/25 06:00 PM
- MoBot alert highlights: NASDAQ: YHC, NASDAQ: JFB, NASDAQ: RLAY, NASDAQ: APDN, NASDAQ: OSRH (09/26/25 05:00 PM)
- Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
- Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025